Medicine by Sfakianakis G. Alexandros: Efficacy Profile and Safety of Very Low-Dose Rituximab in Patients with Graves' Orbitopathy

Thursday, April 1, 2021

Efficacy Profile and Safety of Very Low-Dose Rituximab in Patients with Graves' Orbitopathy

xlomafota13 shared this article with you from Inoreader

Efficacy Profile and Safety of Very Low-Dose Rituximab in Patients with Graves' Orbitopathy

Via liebertpub1

showCoverImage?journalCode=

Thyroid, Ahead of Print.

View on the web

Inoreader. Take back control of your news feed. Follow us on Twitter and Facebook.

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)